Abattis Subsidiary, Northern Vine, Provides Update on Growth Targets (PR)

1 Response Abattis News | Northern Vine | Raybot

VANCOUVER, British Columbia / GLOBE NEWSWIRE / Aug. 23, 2017 Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to provide an update on its subsidiary, Northern Vine Canada Inc. (“Northern Vine”), which specializes in the legal testing and analysis of cannabis products and is expected to soon commence extraction of cannabinoid derivatives […]

Abattis Announces Receipt of Cultivation License by LP Partner (PR)

0 Responses Abattis News | Experion

VANCOUVER, British Columbia / GLOBE NEWSWIRE / Aug. 21, 2017 Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (ATTBF) and its majority-owned testing and laboratory subsidiary, Northern Vine Canada Inc. (“Northern Vine”), are pleased to announce that their Licensed Producer (LP) investment partner, Experion Biotechnologies Inc. (“Experion”), has officially received an Access to Cannabis for […]

Abattis Announces Vergence Update (PR)

0 Responses Abattis News | Vergence

Vancouver, British Columbia / Newsfile Corp. / August 15, 2017 Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the “Company” or “Abattis“) is pleased to provide an update on its wholly-owned subsidiary, Vergence Visionary Bioceuticals (“Vergence”), which is a nutraceutical marketing and brand specialist firm focused on bringing innovative health products to market. New Brand Partnerships […]

Abattis Adds New Product Line to Wholly-Owned Subsidiary Vergence Naturals Distribution Portfolio (PR)

0 Responses Abattis News | Vergence

Vancouver, British Columbia / Newsfile Corp. / August 11, 2017 Abattis Bioceuticals Corp. (CSE: ATT) (OTC: ATTBF) (the “Company” or “Abattis“) is pleased to announce it has reached a deal with Jonny Hetherington Essentials for major distribution of their products throughout North America and potentially Asia, through its wholly-owned subsidiary, Vergence Visionary Bioceuticals (“Vergence” or […]

Abattis Files Amended and Restated Financial Statements For the Period Ended March 31, 2017 (PR)

0 Responses Abattis News | Financial

Vancouver, British Columbia / Newsfile Corp. / August 9, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) announces that, as a result of a review by the British Columbia Securities Commission, we are issuing the following press release to clarify our disclosure. The review identified certain discrepancies in our condensed consolidated […]

Abattis Expands and Strengthens Its Asian Distribution Sales Channels (PR)

0 Responses Abattis News | Management | Vergence

Vancouver, British Columbia / Newsfile Corp. / July 25, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) is pleased to announce the appointment of Mr. Wei Ma to oversee export and business development in Asia, in an effort to further expand and strengthen the Company’s Asian distribution channels. Mr. Ma has […]

Abattis Obtains DTC Eligibility (PR)

0 Responses Abattis News | Vergence

Vancouver, British Columbia / Newsfile Corp. / July 17, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) is pleased to announce that it has obtained Depository Trust Company (“DTC”) eligibility in the United States (“US”). The DTC is a stock depository and facilitates electronic trading in the US. When shares are […]

Abattis Partners with the CSE and Stockpools (PR)

0 Responses Abattis News | Marketing

Vancouver, British Columbia / Newsfile Corp. / July 13, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis”) has partnered with the Canadian Securities Exchange (“CSE”), Stockpools and Lift Cannabis Expo to educate market players on the cannabis industry through an innovative fantasy online stock trading competition focused entirely on the cannabis […]

Abattis Adds Key Executive and Management Positions (PR)

0 Responses Abattis News | Management

Vancouver, British Columbia / Newsfile Corp. / June 15, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) is pleased to announce the following key additions to our Executive and Management team, Anthony Jackson as Chief Financial Officer (“CFO”), Christina Boddy as Corporate Secretary, John Kaye as head of Corporate Development and […]

Abattis Provides Company Update (PR)

0 Responses Abattis News | Northern Vine | Raybot | Vergence

Vancouver, British Columbia / Newsfile Corp. / June 13, 2017 Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the “Company” or “Abattis“) is pleased to provide an update of recent developments and achievements. Testing Revenues at Northern Vine Labs Since the launch of its first lab in May of 2017, the Company’s subsidiary, Northern Vine Canada […]

Abattis Announces New Board Members (PR)

0 Responses Abattis News

Vancouver, British Columbia / Newsfile Corp. / June 7, 2017 Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the “Company” or “Abattis“) is pleased to announce the appointment of Robert Abenante and Peter Gordon to its Board of Directors. Mr. Abenante is the President and CEO of Abattis and its subsidiaries. He is a seasoned executive […]

Abattis: Northern Vine Labs Expands Its Sales Team (PR)

5 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / May 10, 2017 Abattis Bioceuticals Corp. (CSE:ATT) (ATTBF) (the “Company” or “Abattis“) is pleased to announce the addition of Siobhan McCarthy as Sales & Marketing Manager for the Company’s subsidiary Northern Vine Canada Inc. (“Northern Vine“). Ms. McCarthy brings more than 20 years of direct sales and marketing experience to […]

Abattis Announces the Official Launch of Northern Vine Laboratory (PR)

6 Responses Abattis News | Health Canada | Northern Vine | Raybot

Vancouver, British Columbia / Newsfile Corp / May 3, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) is pleased to announce that its subsidiary, Northern Vine Canada Inc. (“Northern Vine“), has officially launched its flagship laboratory, having completed its first successful test analysis. “I am very pleased to announce this significant […]

Abattis Signs Exclusive Distribution Agreement for Proprietary Extraction Technology (PR)

16 Responses Abattis News | Health Canada | Northern Vine | Raybot

VANCOUVER, BC / ACCESSWIRE / April 26, 2017 Abattis Bioceuticals Corp. (CSE:ATT) (ATTBF) (the “Company” or “Abattis“) is pleased to announce that it has signed an exclusive distribution agreement, effective April 20, 2017 (the “Agreement“), with Suzhou Raybot Material Tech Corp. (“Raybot“). The Agreement allows Abattis to use Raybot’s proprietary extraction technology and to exclusively […]

Abattis Bioceuticals Announces New CEO

5 Responses Abattis News | Management | Northern Vine

VANCOUVER, BC / ACCESSWIRE / April 10, 2017 Abattis Bioceuticals Corp. (CSE:ATT) (ATTBF) (the “Company” or “Abattis”) is pleased to announce the appointment of Robert Abenante as President and Chief Executive Officer of the Company. Mr. Abenante is a seasoned executive with extensive public company experience. Mr. Abenante is a Chartered Professional Accountant (CPA, CA) […]

Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC (PR)

3 Responses Abattis News | Marijuana Investment | Northern Vine

VANCOUVER, BC / ACCESSWIRE / April 6, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), is pleased to announce it has officially been added to The Marijuana Index, within the Biotechnology sector. The North American Marijuana Index tracks the leading public cannabis companies operating in the United States and Canada and gives investors […]

Canada’s Plans for Near-term Legalization Puts Testing into Focus (CFN Media)

0 Responses Abattis News | Northern Vine

SEATTLE, WA / Marketwired / Apr 4, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing the planned legalization of cannabis in Canada, the growing and urgent need for testing in both the existing and upcoming legal cannabis markets, and Abattis […]

Abattis: Legislation to Legalize Marijuana in Canada is Being Announced Next Month (PR)

0 Responses Abattis News | Health Canada | Northern Vine

VANCOUVER, BC / ACCESSWIRE / March 27, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), and its subsidiary, Northern Vine Labs, is anticipating the Liberal government’s upcoming announcement, next month (the week of April 10th), on legislation that will legalize recreational marijuana use across Canada by July 1, 2018. As reported by the […]

Abattis Welcomes Dr. David Galvez as Science Advisor to Northern Vine (PR)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / March 20, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce that Dr. David Galvez, PhD, will be joining the team to lead Northern Vine’s Science Advisory efforts. Dr. Galvez received his doctorate in Plant Physiology at the University of Alberta and is a seasoned […]

Abattis Team Positions for Next Stage of Growth (PR)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / March 13, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce the addition of Jaclyn Thomson, PhD, to our senior management team at Northern Vine Labs, and the appointment of Rene David to the Abattis Board of Directors. As the construction and buildout of Northern […]

Abattis Completes Audit and Prepares to Launch Northern Vine Labs (PR)

0 Responses Abattis News | Health Canada | Northern Vine

VANCOUVER, BC / ACCESSWIRE / February 24, 2017 Abattis Bioceuticals Corp. (ATTBF) (CNSX:ATT) (“ATT” or the “Company”) is pleased to announce the completion of their annual audit. The delay in filing was due to an eventful year with new programs coming online and an aggressive strategy to cut non-core assets resulting in prolonged consolidations and […]

Abattis Bioceuticals Corp. Announces Postponement of its Annual General Meeting (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / February 14, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company”) is announcing today that it will be seeking to adjourn its upcoming annual general meeting of shareholders, originally scheduled to be held on Friday, February 17, 2017, at 10:00 a.m. (Vancouver time) (the “Meeting”), to a to-be-announced date. The Company […]

Abattis Explores Diversifying with a Strategic Acquisition (CFN Media)

0 Responses Abattis News | Northern Vine

SEATTLE, WA / Marketwired / Jan 19, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. ( OTC PINK : ATTBF ) ( CNSX : ATT ), a specialty agricultural technology firm focused on the legal cannabis industry. […]

Abattis Announces an Independent Valuation on Green Nature Health Care Products (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / January 16, 2017 Abattis Bioceuticals Corp. (ATTBF) (CNSX:ATT) (the “Company” or “Abattis”) provides an update to its shareholders. Abattis Bioceuticals Corp. has begun an independent valuation on Green Nature Health Care Products Inc. after the company posted strong performance within their existing and upcoming product catalogue in both Q3 and […]

Abattis Bioceuticals (ATTBF) Northern Vine Labs and the New Canadian Rules (CFN Media)

0 Responses Abattis News | Health Canada | Northern Vine

SEATTLE, WA / Marketwired / Jan 5, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Abattis Bioceuticals Corp.’s ( OTCQB : ATTBF ) ( CSE : ATT ) Northern Vine Labs subsidiary and the effect newly proposed rules in Canada […]

Abattis Provides Corporate Update (PR: 12/16/16)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / December 16, 2016 Abattis Bioceuticals Corp. (ATTBF) (CNSX:ATT) (the “Company” or “Abattis”) provides an update to its shareholder. CEO Rene David provides an update to shareholders after reviewing the latest report from the Canadian Cannabis Task Force on Legalization and Regulation. “After having a chance to review the report, we are even […]

Abattis (ATTBF) Targets Emerging Markets with Nutraceutical Business (CFN Media)

0 Responses Abattis News

SEATTLE, WA / Marketwired / Nov 28, 2016 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Abattis Bioceuticals Corp.’s ( OTCQB : ATTBF ) ( CSE : ATT ) recent expansion of distribution lines in Asia and how those efforts complement […]

Abattis Announces the Appointment of Dr. Shuang Xie as a Director and Provides Progress Report on Initiatives in China (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / November 14, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), is pleased to announce the appointment of Dr. Shuang Xie to the Board of Directors. Dr. Xie recently joined Abattis as the Chief Technology Advisor and continues in that capacity. Abattis is also pleased provide an update on […]

Abattis Announces Renewal of Health Canada Licence (PR)

0 Responses Abattis News | Health Canada

VANCOUVER, BC / ACCESSWIRE / November 7, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), announces the renewal of the Health Canada Licence for the Northern Vine Canada Inc. testing lab. Health Canada has confirmed the renewal of the Langley, BC facility’s controlled substances testing licence. The Company has fulfilled Health Canada’s rigorous […]